Evidence map›Paper›PMID 35273077›Full record

ArticleGenes & development2022

Nucleolar-based

Sheila Q Xie, Bryony J Leeke, Chad Whilding, Ryan T Wagner, Ferran Garcia-Llagostera, YiXuan Low, Paul Chammas, Nathan T-F Cheung, Dirk Dormann, Michael T McManus and 1 more

Open access · diamondAbstract read
In one paragraph

Article in Genes & development, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 60 citations in OpenAlex.

  1. Article
  2. Article
  3. Chromatin topology control by a muscle-specific ribosomal protein.bioRxiv : the preprint server for biology · 2026
    Article
  4. Article
  5. Exit from totipotency in mammals: an epigenetic perspective.Frontiers in cell and developmental biology · 2026
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Sheila Q XieMRC London Institute of Medical Sciences, London W12 0NN, United Kingdom.
Bryony J LeekeMRC London Institute of Medical Sciences, London W12 0NN, United Kingdom.
Chad WhildingMRC London Institute of Medical Sciences, London W12 0NN, United Kingdom.
Ryan T WagnerUniversity of California at San Francisco, San Francisco, California 91413, USA.
Ferran Garcia-LlagosteraMRC London Institute of Medical Sciences, London W12 0NN, United Kingdom.
YiXuan LowMRC London Institute of Medical Sciences, London W12 0NN, United Kingdom.
Paul ChammasMRC London Institute of Medical Sciences, London W12 0NN, United Kingdom.
Nathan T-F CheungMRC London Institute of Medical Sciences, London W12 0NN, United Kingdom.
Dirk DormannMRC London Institute of Medical Sciences, London W12 0NN, United Kingdom.
Michael T McManusUniversity of California at San Francisco, San Francisco, California 91413, USA.
Michelle PerchardeMRC London Institute of Medical Sciences, London W12 0NN, United Kingdom.
MRC London Institute of Medical Sciences · GBImperial College London · GBUniversity of San Francisco · US

Funding

Regulation of developmental potency by the transposon LINE1R01GM123556 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MCMANUS, MICHAEL T · 2017 to 2020
$1.6M
Medical Research Council MC_EX_MR/S015930/1Medical Research Council MC_UP_1605/4NIGMS NIH HHS R01 GM123556
6 · The paper itself

Abstract

Upon fertilization, the mammalian embryo must switch from dependence on maternal transcripts to transcribing its own genome, and in mice this involves the transient up-regulation of MERVL transposons and MERVL-driven genes at the two-cell stage. The mechanisms and requirement for MERVL and two-cell (2C) gene up-regulation are poorly understood. Moreover, this MERVL-driven transcriptional program must be rapidly shut off to allow two-cell exit and developmental progression. Here, we report that robust ribosomal RNA (rRNA) synthesis and nucleolar maturation are essential for exit from the 2C state. 2C-like cells and two-cell embryos show similar immature nucleoli with altered structure and reduced rRNA output. We reveal that nucleolar disruption via blocking RNA polymerase I activity or preventing nucleolar phase separation enhances conversion to a 2C-like state in embryonic stem cells (ESCs) by detachment of the MERVL activator

Indexed as

Cell NucleolusEmbryo, MammalianAnimalsEmbryonic DevelopmentEmbryonic Stem CellsGenomeMammalsMiceRNA, RibosomalRNA, Ribosomal2C-like stateDuxMERVLnucleolustotipotency

Identifiers

PMID35273077
PMCPMC8973846
OpenAlexW4220734053

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.